Geoff Meacham Initiated (ALNY) at Buy with Increased Target to $105 on, Sep 7th, 2017
Geoff Meacham of Barclays, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $80 to $105 on, Sep 7th, 2017.
Geoff has made no other calls on ALNY in the last 4 months.
There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, all agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $50 on, Thursday, August 10th, 2017
Similar House and Home Articles
[ Tue, Sep 05th 2017
] - WOPRAI
[ Fri, Aug 25th 2017
] - WOPRAI
[ Wed, Aug 23rd 2017
] - WOPRAI
[ Fri, Aug 18th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Mon, Jul 10th 2017
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Wed, Aug 10th 2016
] - WOPRAI
[ Tue, Nov 10th 2015
] - WOPRAI
[ Mon, Aug 31st 2015
] - WOPRAI